Skip to content

The impact of perioperative whole process pulmonary rehabilitation intervention on postoperative outcomes in lung cancer patients: a prospective, cohort, investigator-initiated trial

The impact of perioperative whole process pulmonary rehabilitation intervention on postoperative outcomes in lung cancer patients: a prospective, cohort investigator-initiated trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085997
Enrollment
Unknown
Registered
2024-06-24
Start date
2024-06-30
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

rehabilitation group:Perioperative whole process pulmonary rehabilitation
Control group:Routine management

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria (1) Patients with high suspicion of lung malignancy and planning to undergo lobectomy or anatomical lung resection; (2) Age>18 years old; (3) Expected survival = 3 months; (4) There are no potential contraindications related to pulmonary rehabilitation, including those who have experienced myocardial infarction or cerebrovascular accident within six months; Chronic heart failure, unstable angina, severe arrhythmia, severe left heart function impairment, acute pulmonary embolism or embolism, severe lower limb vasculitis or limb dysfunction, etc; (4) Ethical entrants; (5) Those who agree to participate in the study and sign an informed consent form after being informed of their medical condition.

Exclusion criteria

Exclusion criteria: Exclusion criteria (1) Postoperative pathology confirmed non lung malignant tumor patients; (2) Intraoperative bleeding greater than 1000ml or conversion to open chest surgery; (3) There are contraindications related to lung rehabilitation, as mentioned above; (4) Other contraindications related to exercise, such as active hemoptysis and untreated pneumothorax; (5) Researchers believe that patients may have other factors that may affect the efficacy or safety evaluation of this study.

Design outcomes

Primary

MeasureTime frame
postoperative pulmonary complications (PPCs) rate;

Secondary

MeasureTime frame
the European Organization for Research and Treatment of Cancer QOL Questionnaire LC-43 (EORTC QLQ-LC43);Leicester cough questionnaire (LCQ);M. D.Anderson SymptomInventory (MDASI-C);Static lung function ;in-hospital stay;

Countries

China

Contacts

Public ContactGuowei Che

West China Hospital of Sichuan University

cheguoweixw@126.com+86 151 8433 8538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026